Abstract

BackgroundJIA is the commonest rheumatologic disease of childhood with a quoted prevalence of 1:1000. Assessment of children with JIA includes:Clinical, laboratory and more recently US evaluation of joints. Rapid attainment...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Comparison Between Clinical and Ultrasound Assessment of the Ankle Region in Children With Juvenile Idiopathic Arthritis.
Denise P Marafon ... Adele Civino
Arthritis care & research | VOL. 73
Denise P Marafon, et. al.Denise P Marafon ... Adele Civino
12 Jul 2021
Frequent discordance between clinical and musculoskeletal ultrasound examinations of foot disease in juvenile idiopathic arthritis
Roger D Sturrock ... Gordon J Hendry
Arthritis Care & Research | VOL. 64
Roger D Sturrock, et. al.Roger D Sturrock ... Gordon J Hendry
28 Feb 2012
SAT0510 Grey-Scale Ultrasonography with Power Doppler Technique: an Available Tool for the Assessment of Subclinical Joint Inflammatory Activity in Juvenile Idiopathic Arthritis
G Genaro ... R Merino
Annals of the Rheumatic Diseases | VOL. 72
G Genaro, et. al.G Genaro ... R Merino
01 Jun 2013
THU0318 A prospective comparative study of three methods of assessment of the knee joint in juvenile idiopathic arthritis: Clinical examination, ultrasound and MRI. (a newly developed knee mri scoring system)
M Mc Carron ... M Wray
Annals of the Rheumatic Diseases | VOL. 71
M Mc Carron, et. al.M Mc Carron ... M Wray
01 Jun 2013
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers